The prostate cancer research team led by Dr. Peter Pinto at the National Cancer Institute has just published some interesting new information on risk for disease progression in men on active surveillance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, biopsy, follow-up, MRI/TRUS fusion, risk, surveillance | Leave a comment »
You may have noticed that your sitemaster has become a tad obsessed with the ways in which active surveillance is being carried out at different centers and the potential for standardization of this process in the interests of definable groups of patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: active, care, continuity, follow-up, surveillance | 1 Comment »
Alan Katz has now published the study with the longest-running follow-up of any study of external beam radiation therapy for prostate cancer among low-risk patients, in this case using SBRT. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 10-year, body, follow-up, SBRT, stereotactic | 2 Comments »
Sometimes it’s easier to blame the patient than it is to blame the medical system, and so that’s what people often do. But if one is going to blame the patient, then one really ought to have data to back it up. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active, care, compliance, follow-up, plan, surveillance | 3 Comments »
Many of us are faced with the difficulty of choosing a primary therapy based on data from clinical trials with follow-up shorter than our life expectancy. How can we know what to expect in 20 or 30 years? … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: follow-up, outcomes, relevance, time | 18 Comments »
So there is an interesting new paper on the ramifications of active surveillance in the forthcoming June issue of the Journal of Urology — based on the extensive data now collected by the Johns Hopkins group through their very conservative active surveillance cohort of > 1,200 men accumulated since 1995. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active surveillance, follow-up, Hopkins, outcome, re-classification | 3 Comments »
Could more intensive monitoring of PSA levels in the first few months after a radical prostatectomy help to determine which patients who have a positive surgical margin (PSM) need adjuvant radiation therapy and which don’t? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: follow-up, margin, positive, PSA, surgery, surgical | 4 Comments »
A new article in European Urology offers interesting data on the natural history of localized prostate cancer, based on a cohort of 200+ Swedish patients followed for > 30 years. It is important to note immediately that none of these men was originally diagnosed in the PSA era. They all had some form of symptomatic disease at diagnosis. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: follow-up, long-term, monitoring, natural history, observation | 17 Comments »
We are having a hard time with a media release issued yesterday by BJU International in relation to a study just published in that journal by Tewari et al. (Actually, we are having a hard time with the results of the study itself too.) … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: age, follow-up, orgasm, potency, RALP, sexual function | 4 Comments »
According to new data presented at the Frontiers in Cancer Prevention Research meeting ongoing this week in Boston, MA, some 70 percent of prostate cancer patients participating in a survey in Michigan reported long-term, treatment-related, adverse effects after first-line treatment with surgery or radiation therapy. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, follow-up, lontg-term, radiation, surgery | 6 Comments »
A paper currently “in press” in the Journal of Urology suggests that annual PSA testing “may be safely discontinued after 10 years for men with a prostatectomy Gleason score 6 or less and/or limited life expectancy.” … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: follow-up, monitoring, outcomes, PSA, radical prostatectomy | 26 Comments »
For any man with a first-time PSA level > 10 ng/ml, there is significant risk for prostate cancer, and early follow-up care — including a repeat PSA test and potentially a biopsy — is probably a priority unless the patient has a life expectancy of 10 years or less. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: care, delay, Diagnosis, follow-up, work-up | Leave a comment »
It has long been understood that a finding of “atypia” (atypical small acinar proliferation) on an initial biopsy of the prostate is associated with an increased risk for prostate cancer, and a repeat biopsy is normally recommended for any patient with an initial finding of atypia. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: acinar proliferation, ASAP, atypia, biopsy, follow-up | 3 Comments »
A new paper based on the cohort of patients being followed with active surveillance (AS) at Memorial Sloan-Kettering Cancer Center (MSKCC) has added to our understanding of the potentially optimal management of patients on AS. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: active surveillance, AS, follow-up, outcome | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 